Key result
A non-invasive diagnostic nomogram incorporating hypertension, age, and laboratory markers demonstrated good predictive accuracy for identifying heart failure in patients with coronary heart disease, with an AUC of 0.720.
Why the study?
Heart failure is an end-stage manifestation of and cause of death in coronary heart disease, motivating the development of a non-invasive diagnostic nomogram to identify heart failure in these patients.
Does a non-invasive diagnostic nomogram based on routine clinical and laboratory factors accurately identify heart failure in patients with coronary heart disease?
Cohort (n=44,772)
Yes
Does a non-invasive diagnostic nomogram based on routine clinical and laboratory factors accurately identify heart failure in patients with coronary heart disease?
A novel non-invasive nomogram using seven routine clinical and laboratory variables provides moderate accuracy (AUC ~0.72) for identifying heart failure in patients with coronary heart disease.
Answers are grounded in this paper and cite their sources.
May aid HF detection in CHD; hypothesis-generating and requires prospective validation before adoption.
Background: Heart failure (HF) is an end-stage manifestation of and cause of death in coronary heart disease (CHD). The objective of this study was to establish and validate a non-invasive diagnostic nomogram to identify HF in patients with CHD. Methods: We retrospectively analyzed the clinical data of 44,772 CHD patients from five tertiary hospitals. Univariate logistic regression analyses and least absolute shrinkage and selection operator (LASSO) regression analyses were used to identify independent factors. A nomogram based on the multivariate logistic regression model was constructed using these independent factors. The concordance index (C-index), receiver operating characteristic (ROC) curves, calibration curves, decision curve analysis (DCA), and clinical impact curves (CIC) were used to evaluate the predictive accuracy and clinical value of this nomogram. Results: The predictive factors in the multivariate model included hypertension, age, and the total bilirubin, uric acid, urea nitrogen, triglyceride, and total cholesterol levels. The area under the curve (AUC) values of the nomogram in the training set, internal validation set, external validation set1, and external validation set2 were 0.720 (95% CI: 0.712-0.727), 0.723 (95% CI: 0.712-0.735), 0.692 (95% CI: 0.674-0.710), and 0.655 (95% CI: 0.634-0.677), respectively. The calibration curves indicated that the nomogram had strong calibration. DCA and CIC indicated that the nomogram can be used as an effective tool in clinical practice. Conclusion: The developed predictive model combines the clinical and laboratory factors of patients with CHD and is useful in individualized prediction of HF probability for clinical decision-making during treatment and management.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2022) conducted a cohort in Coronary heart disease (CHD) (n=44,772). Non-invasive diagnostic nomogram was evaluated on Predictive accuracy (Area Under the Curve) of the nomogram for identifying heart failure in the training set (AUC 0.720, 95% CI 0.712-0.727). A non-invasive diagnostic nomogram incorporating hypertension, age, and laboratory markers demonstrated good predictive accuracy for identifying heart failure in patients with coronary heart disease, with an AUC of 0.720.
Synapse has enriched 10 related papers. Consider them for comparative context: